Edith de Boer is the HR Director for Zimmer Biomet in Australia and New Zealand. Her career originally was in telecommunications and consulting in Europe. After leaving The Netherlands, Edith worked into the Australian medical research industry, before moving into a human resources role at Zimmer Biomet. Edith spoke to Australian Health Journal about her role and the organisation.
Promoting medical technology as an industry is important for Zimmer Biomet. The organisation runs a program called “Your future in STEM” helping girls at high school children consider STEM as a career, through to career professionals in the “Women-Inspired Network” or WIN as it’s commonly referred to. In clinical professions, the Zimmer Biomet “Women in Orthopaedics” program for female surgeons, acts in an advocate and support role.
Collaboration and work mindset of one team is very important for the organisation, as well as employees having a sense of belonging and being included. So whilst, talent can be difficult to find in the current market, Zimmer Biomet staff are together taking a journey of change that’s occurring across the industry.
Upbeat Edith’s energy is refreshing! Anyone looking to enter the medical technology industry and specifically the humans resources role can make a difference to people’s lives. Her advice? Be creative, work hard and have a growth mindset.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
-
Budget22 A mixed dose of health outcomes
Australian Health Journal met with a number of industry heads after the budget on their journeys so far in lobbying for change, their achievements, some of the disappointments and their thoughts on the road ahead, with an election round the corner.
-
Sovereign capability uplifted
Skilled labour, in particular skilled in the manufacture of MTP products, namely competency in Good Manufacturing Practice (GMP), was identified as one of the key priorities, according to Jarrod Belcher, Director of the REDI Program at MTPConnect. Through a competitive process, MTPConnect selected additional industry training providers to deliver new programs addressing key skills gaps in the sector workforce.
Launched in September 2022, one of these programs is GMP Uplift developed by the Centre for Biopharmaceutical Excellence (CBE). CBE bring experience across large and small Biologics, Pharmaceuticals and Regenerative Medicine companies, both in consulting and GMP related enterprise training. CBE staff also have extensive experience in GMP operations, compliance, auditing and QMS design, a wide industry network for guest lecturers and readily available case studies.
